CR rates for patients randomized to either DA or ATRA
| . | DA, % . | ATRA, % . |
|---|---|---|
| All patients | 70 | 73 |
| Age, y | ||
| Younger than 15 | 60 | 74 |
| 15 to 55 | 71 | 76 |
| 56 to 65 | 74 | 69 |
| Older than 65 | 69 | 53 |
| WBC, per μL | ||
| Less than 2000 | 69 | 84 |
| 2000 to less than 5000 | 71 | 68 |
| 5000 to less than 10 000 | 68 | 50 |
| 10 000 or more | 71 | 65 |
| Morphology | ||
| Classical M3 | 68 | 73 |
| M3v | 80 | 71 |
| Sex | ||
| Male | 73 | 74 |
| Female | 65 | 72 |
| . | DA, % . | ATRA, % . |
|---|---|---|
| All patients | 70 | 73 |
| Age, y | ||
| Younger than 15 | 60 | 74 |
| 15 to 55 | 71 | 76 |
| 56 to 65 | 74 | 69 |
| Older than 65 | 69 | 53 |
| WBC, per μL | ||
| Less than 2000 | 69 | 84 |
| 2000 to less than 5000 | 71 | 68 |
| 5000 to less than 10 000 | 68 | 50 |
| 10 000 or more | 71 | 65 |
| Morphology | ||
| Classical M3 | 68 | 73 |
| M3v | 80 | 71 |
| Sex | ||
| Male | 73 | 74 |
| Female | 65 | 72 |
CR indicates complete remission. Other abbreviations are explained in the footnote to Table 1.